Methods for testing for and handling non-proportional hazards in a phase II rct in chronic lymphocytic leukaemia

被引：0
|
作者：
McParland, Lucy [1 ]
Howard, Dena R. [1 ]
机构：
[1] Univ Leeds, Leeds, W Yorkshire, England
来源：
TRIALS | 2017年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
P448
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Comparison of methods to testing for differential treatment effect under non-proportional hazards data
    Pardo, Maria del Carmen
    Cobo, Beatriz
    [J]. MATHEMATICAL BIOSCIENCES AND ENGINEERING, 2023, 20 (10) : 17646 - 17660
  • [2] Methods for non-proportional hazards in clinical trials: A systematic review
    Bardo, Maximilian
    Huber, Cynthia
    Benda, Norbert
    Brugger, Jonas
    Fellinger, Tobias
    Galaune, Vaidotas
    Heinz, Judith
    Heinzl, Harald
    Hooker, Andrew C.
    Klinglmueller, Florian
    Koenig, Franz
    Mathes, Tim
    Mittlboeck, Martina
    Posch, Martin
    Ristl, Robin
    Friede, Tim
    [J]. STATISTICAL METHODS IN MEDICAL RESEARCH, 2024, 33 (06) : 1069 - 1092
  • [3] Analysis of survival data from trials with non-proportional hazards: an empirical comparison of methods
    Patrick Royston
    Yinghui Wei
    Jayne Tierney
    Mahesh Parmar
    [J]. Trials, 14 (Suppl 1)
  • [4] Critical reappraisal of phase III trials with immune checkpoint inhibitors in non-proportional hazards settings
    Castanon, Eduardo
    Sanchez-Arraez, Alvaro
    Alvarez-Mancenido, Felipe
    Jimenez-Fonseca, Paula
    Carmona-Bayonas, Alberto
    [J]. EUROPEAN JOURNAL OF CANCER, 2020, 136 : 159 - 168
  • [5] Analysis techniques in the presence of non-proportional hazards (PH); application to an ovarian cancer RCT with long-term follow-up
    Morden, James
    Bliss, Judith
    Eeles, Rosalind
    [J]. TRIALS, 2015, 16
  • [6] Analysis techniques in the presence of non-proportional hazards (PH); application to an ovarian cancer RCT with long-term follow-up
    James Morden
    Judith Bliss
    Rosalind Eeles
    [J]. Trials, 16
  • [7] Statistical methods of indirect comparison with real-world data for survival endpoint under non-proportional hazards
    Lin, Zihan
    Zhao, Dan
    Lin, Junjing
    Ni, Ai
    Lin, Jianchang
    [J]. JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2022, 32 (04) : 582 - 599
  • [8] Stochastic curtailment tests for phase II trial with time-to-event outcome using the concept of relative time in the case of non-proportional hazards
    Sharma, Palash
    Phadnis, Milind A.
    [J]. JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2024, 34 (04) : 596 - 611
  • [9] Alemtuzumab consolidation in chronic lymphocytic leukaemia: a phase I/II multicentre trial
    Al-Sawaf, Othman
    Fischer, Kirsten
    Herling, Carmen D.
    Ritgen, Matthias
    Boettcher, Sebastian
    Bahlo, Jasmin
    Elter, Thomas
    Stilgenbauer, Stephan
    Eichhorst, Barbara F.
    Busch, Raymonde
    Elberskirch, Ute
    Abenhardt, Wolfgang
    Kneba, Michael
    Hallek, Michael
    Wendtner, Clemens-Martin
    [J]. EUROPEAN JOURNAL OF HAEMATOLOGY, 2017, 98 (03) : 254 - 262
  • [10] A phase II trial of fludarabine in patients with previously treated chronic lymphocytic leukaemia
    Hocepied, AMLJ
    Falkson, CI
    Falkson, G
    [J]. SOUTH AFRICAN MEDICAL JOURNAL, 1996, 86 (05): : 549 - 550
12345